AARTIDRUGS
₹545.0521.85 (4.18%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Record high net sales in the latest quarter indicate strong demand for products.
- Improved operating margin in the latest quarter shows better cost management and operational efficiency.
- Noticeable growth in net profit in the latest quarter suggests effective financial strategies.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Sep 23 | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 641.54 | 605.94 | 619.99 | 555.34 | 598.33 | 556.60 | 676.76 | 590.51 | |
| Expenses | 585.95 | 556.06 | 556.89 | 512.47 | 553.93 | 517.74 | 607.48 | 539.71 | |
| Operating Profit | 55.59 | 49.88 | 63.10 | 42.87 | 44.40 | 38.86 | 69.28 | 50.80 | |
| Other Income | 0.68 | 1.67 | 1.08 | 1.11 | 1.48 | 11.90 | 1.87 | 0.31 | |
| Interest | 8.25 | 7.60 | 9.13 | 8.71 | 8.93 | 9.07 | 9.16 | 8.56 | |
| Depreciation | 12.61 | 12.66 | 13.58 | 13.38 | 13.72 | 13.80 | 14.88 | 14.72 | |
| Profit Before Tax | 56.27 | 51.55 | 64.18 | 43.98 | 45.88 | 50.76 | 71.15 | 51.11 | |
| Tax | 16.67 | 14.84 | 16.87 | 10.71 | 10.92 | 13.67 | 8.38 | -2.86 | |
| Net Profit | 39.60 | 36.71 | 47.31 | 33.27 | 34.96 | 37.09 | 62.77 | 53.97 | |
| EPS in Rs | 4.29 | 3.99 | 5.15 | 3.62 | 3.83 | 4.06 | 6.88 | 5.91 |